Drug Report History #257924

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.

Field Version v2-FR Version v1-EN
Language French (Updated) English
Date Updated 2026-01-05 2026-01-05
Drug Identification Number 02243297 02243297
Brand name GLUCAGON GLUCAGON
Common or Proper name zxcvxz zxcvxz
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients GLUCAGON GLUCAGON
Strength(s) 1MG 1MG
Dosage form(s) POWDER FOR SOLUTION KIT POWDER FOR SOLUTION KIT
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size ZC ZC
ATC code H04AA H04AA
ATC description GLYCOGENOLYTIC HORMONES GLYCOGENOLYTIC HORMONES
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2024-01-15 2024-01-15
Actual start date
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments